Compare SCTX & PMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCTX | PMO |
|---|---|---|
| Founded | N/A | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.1M | 282.5M |
| IPO Year | 2026 | 1994 |
| Metric | SCTX | PMO |
|---|---|---|
| Price | $27.59 | $10.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 187.6K | 61.7K |
| Earning Date | N/A | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.10% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $25.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $9.72 |
| 52 Week High | $26.50 | $10.87 |
| Indicator | SCTX | PMO |
|---|---|---|
| Relative Strength Index (RSI) | 63.58 | 51.22 |
| Support Level | $19.09 | $10.39 |
| Resistance Level | N/A | $10.50 |
| Average True Range (ATR) | 2.75 | 0.11 |
| MACD | 0.21 | 0.03 |
| Stochastic Oscillator | 96.86 | 62.24 |
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Putnam Municipal Opportunities Trust is a non-diversified closed-end management investment company. It seeks to provide as high a level of current income free from federal income tax as Putnam Management believes is consistent with the preservation of capital. The fund invests in healthcare, utilities, transportation, leases, local, Housing, education, and Others.